Fuse Oncology

Fuse Oncology

Private
Boone, North CarolinaEnterprise Softwarehttps://www.fuseonc.com

Last Round

VC Round

Sep 8, 2023

Momentum Score

25 /100

Company Overview

Fuse Oncology, Inc. is a software solutions provider that spun out of Cone Health in 2021. The company develops and delivers a suite of AI-powered SaaS solutions for the radiation oncology market, designed to break down workflow and data silos. Its products, such as S!GNAL and FuseDocs, aim to improve clinical efficiency, streamline documentation, automate billing, and reduce errors in the revenue cycle. By integrating with existing healthcare technologies like EMR and OIS systems, Fuse Oncology seeks to accelerate care pathways and allow clinicians to focus more on patient care. The company is venture-backed, having closed a Series A funding round in 2023.

Sector

Enterprise Software

Verticals

Workflow Automation, Vertical SaaS, Revenue Cycle, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncology softwareworkflow automationEHR integrationradiation oncologyrevenue cycle managementOIS integrationcharge capturevertical SaaScancer center softwareclinical systems integrationhealthcare analyticsplatform-as-a-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fuse Oncology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fuse Oncology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 8, 2023
Series AJun 1, 2023

Key People

Founding team and executive leadership

Benjamin Sintay

Chief Innovation Officer, Co-Founder

Founding Team

James Bauler

Chief Executive Officer

Executive Team

Christel Smith

Chief Technology Officer

Executive Team

Fuse Oncology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 26, 2025

    Showcased live clinical AI solutions at ASTRO 2025.

  • Mar 13, 2025

    Developing a dedicated application for ACROPath to enhance clinical workflows.

Fuse Oncology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fuse Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fuse Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoone, North Carolina
Employee Range28
Year Founded2021
Last FundingSep 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.